检索

The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation)

Vaschenko L., Dashkova I., Kechedzhieva E., Babieva S.

卷 23, 编号 4 (2021)

Targeted therapy of brain metastases in patients with ALK-positive non-small cell lung cancer: A review

Sakaeva D., Bulavina I.

(Rus)

卷 20, 编号 3 (2018)

Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo

Novikov D., Polotskiy B., Bogush T., Davidov M., Ahmedov B., Rotobelskaya L.

(Rus)

Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer

Editorial B.

(Rus)

PARP inhibitors in female reproductive system cancers

Pokataev I., Tyulyandin S.

(Rus)

卷 24, 编号 3 (2022)

Classification of breast cancer subtypes based on RNA profiling and immunohistochemical methods: clinical and biological aspects: A review

Imyanitov E.

(Rus)

卷 24, 编号 1 (2022)

Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research

Kolomejtseva A., Bokova S.

(Rus)

卷 22, 编号 1 (2020)

Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer

Kolyadina I., Danzanova T., Khokhlova S., Trofimova O., Kovaleva E., Rodionov V., Poddubnaya I.

(Rus)

卷 20, 编号 3 (2018)

The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer

Kolyadina I., Poddubnaya I.

(Rus)

Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives

Yudin D., Laktionov K., Laktionova L., Breder V.

(Rus)

卷 21, 编号 3 (2019)

Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer

Musaeva Z., Chekalova M., Mesheryakov A.

(Rus)

卷 20, 编号 2 (2018)

The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan

Berdimyradova M., Khadjiev S., Khommadova D., Polatova G., Kakajanova A., Batyrov C., Penayev D., Agayeva B., Annaberdiyeva G.

(Rus)

Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers

Stilidi I., Kotyukova A., Lyadov V.

(Rus)

卷 18, 编号 1 (2016)

Rare morphological forms of breast cancer: features of surgical approach

Vysotskaya I., Letyagin V., Kolyadina I., Martynova G.

(Rus)

Regorafenib in metastatic colorectal cancer: more data for clinical decisions

Petkau V., Karimova A., Akishina Z.

(Rus)

卷 21, 编号 3 (2019)

The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer

Gordeeva O., Kolyadina I., Zhukova L., Gan'shina I., Komov D., Meshcheriakov A.

(Rus)

卷 15, 编号 1 (2013)

Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies

Kit O., Vladimirova L., Sholokhova E.

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer

Ognerubov N.

(Rus)

卷 21, 编号 1 (2019)

The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)

Morozov D., Kolyadina I., Poddubnaya I., Chumakov P., Ilinskaya G., Bokhian V., Sopova M.

(Rus)

Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib

Sekacheva M., Nuriev R., Rozhkov A., Semenkov A., Bagmet N., Boroda A.

(Rus)

卷 21, 编号 3 (2019)

Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer

Reutova E., Laktionov K., Iudin D., Neliubina L., Gorokhova G., Egorova A.

(Rus)

卷 20, 编号 3 (2018)

Clinical prognostic factors of bilateral synchronous renal cancer

Komarov M., Matveev V., Volkova M., Komarov I., Ridin V.

(Rus)

The role of bevacizumab in the treatment of patients with ovarian and cervical cancer

Khokhlova S.

(Rus)

Neuroendocrine tumors of the colon: an analysis of the literature and own experience

Kochatkov A., Bogomazova S., Negardinov A., Alimova Y., Lyadov V.

(Rus)

卷 16, 编号 1 (2014)

The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program

Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.

卷 18, 编号 2 (2016)

Second primary cancer in patients with head and neck squamous cell carcinoma: case report

Agabekyan G., Stelmakh D., Aydarbekova A.

(Rus)

卷 26, 编号 1 (2024)

Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study

Levashov A., Zagidullina S., Valiev T., Stroganova A., Khochenkov D., Grigorenko V., Mikhaylova E., Tyurina E., Ryzhova M., Horielyshev S., Kadyrov S., Polyakov V.

(Rus)

卷 25, 编号 2 (2023)

Nutritional support for primary patients with esophageal cancer (analytical review)

Obukhova O., Kurmukov I., Abu-Khaidar O.

(Rus)

Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer

Pavlikova O., Kolyadina I., Komov D., Vishnevskaya Y., Poddubnaya I.

(Rus)

Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas

Borisov P., Orlova R., Shkolnik M., Karlov P.

卷 15, 编号 2 (2013)

Prognostic value of p53 expression in patients with stage I breast cancer

Kolyadina I., Poddubnaya I., Van de Velde C., Kuppen P., Liefers G., Dekker-Ensink N., Bastiaannet E., Van As-Sajet A., Prinse B., Engels C., Van Vlierberghe R., Komov D., Karseladze A., Ermilova V., Vishnevskaya Y., Frank G., Banov S.

Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report

Protasova A., Strakh L., Lando E., Sidorkina E.

(Rus)

The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report

Ognerubov N., Antipova T.

(Rus)

Treatment of advanced small cell lung cancer. Clinical case and literature review

Menshikov K., Sultanbaev A., Musin S., Menshikova I., Nasretdinov A., Sultanbaeva N.

(Rus)

Role and place of PARP inhibitors in the modern treatment algorithm of BRCA-associated HER2-negative metastatic breast cancer. Results of the educational and discussion events based on the “OncoForum” platform

Board E.

(Rus)

卷 22, 编号 4 (2020)

Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor

Ganshina I., Ivanova K., Lubennikova E., Arkhipov A., Zhukova L.

(Rus)

Stomach cancer. Clinical significance of the expression of key components of PD-1/PD-L1 immune checkpoint

Kovaleva O., Podlesnaya P., Gratchev A., Chang V., Ognerubov N., Kushlinskii N.

(Rus)

Prospects for the development of adjuvant therapy for non-small cell lung cancer

Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.

(Rus)

卷 22, 编号 1 (2020)

The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study

Kovalenko E., Artamonova E., Karabina E., Andreiashkina I., Prokof’eva E., Popova N., Gaisina E., Evstigneeva I., Shaidorov M., Zhiliaeva L., Ponomarenko D., Khasanova A., Mukhametshina G., Koziakov A., Vorotilina L., Povyshev A., Simolina E., Marfutov V., Kozlov D., Suslova I., Shikina V., Karandeeva T., Shepel’ A., Kramskaia L., Oskirko D., Frolova O.

(Rus)

卷 21, 编号 2 (2019)

Modern ultrasound diagnostics for locally advanced cervical cancer

Ovodenko D., Khabas G., Makarova A., Pirogova M., Seregin A., Golitsyna Y., Ashrafyan L.

(Rus)

卷 21, 编号 1 (2019)

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia

Gorbunova V., Kolyadina I., Kovalenko E., Manziuk L., Artamonova E., Zhukova L., Bolotina L., Semiglazova T., Manikhas A., Raevskaia N., Itkin I., Filonenko D., Zhilyaeva L., Gol'dberg V., Popova N., Ponomarenko D., Shikina V., Suslova I., Romanchuk O., Kozlov D., Rzaev A., Marfutov V., Andreiashkina I., Vladimirova L., Mitashok I., Tikhanovskaia N., Karabina E., Mukhametshina G., Khasanova A., Safina S., Shaidorov M., Morozov D., Prokof'eva E., Kramskaia L., Karandeeva T., Evstigneeva I., Ovchinnikova E., Klement'eva T., Khrupalo O., Tiuvinova E., Sherstnev V., Chernov I., Kolokolov D., Gaisina E., Levchenko N., Chubenko V., Povyshev A., Iudina I., Vorotilina L., Andreeva T., Tumanian G., Koziakov A., Gil'mutdinova L., Osipov M., Shatokhina A., Vazhenina A., Chichkanova A., Vladimirov V., Ivanov A., Belokhvostova A., Cherniakova E., Tul'china E., Maklashova S., Shkodenko O., Kostalanova I., Tarasova A., Kuz'mina E.

(Rus)

卷 20, 编号 4 (2018)

A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer

Lozovaya V., Cherkes L., Malikhova O., Poddubny B.

(Rus)

卷 20, 编号 2 (2018)

New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors

Laktionov K., Reutova E., Nelyubina L., Pitkevich M., Okruzhnova M., Ardzinba M., Yudin D., Demidova I., Zaretsky A.

(Rus)

卷 20, 编号 1 (2018)

Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus

Shogenov M., Davydov M., Allakhverdiyev A., Chekini A., Filatov A., Akhmedov P., Serebryanskaya M., Korolyeva A., Dadyev I., Chichikov E., Grigorenko V., Kozlov N., Nazliyev P., Malikhova O., Tryakin A.

(Rus)

Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer

Kit O., Vladimirova L., Abramova N., Storozhakova A., Popova I., Tikhanovskaya N., Lyaynova A., Ryadinskaya L.

(Rus)

Albumin-bound paclitaxel in the treatment of metastatic breast cancer

Artamonova E.

(Rus)

Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council

Rumyantsev P., Gorbunova V., Podvyaznikov S., Zhukov N., Isaev P., Krylov V., Mudunov A., Rodichev A., Shavarova E.

(Rus)

The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer

Frolova M.

(Rus)

卷 18, 编号 1 (2016)

Long-term effects of pediatric cancer therapy: 35-year clinical experience

Zaeva G., Valiev T., Gavrilenko T., Moiseenko E., Medvedovskaya E., Mikhailova S., Sinyagina Y.

(Rus)

卷 17, 编号 3 (2015)

Latent herpes virus infection in the carcinogenesis of bladder cancer

Loran O., Sinyakova L., Gundorova L., Kosov V., Kosova I., Kolbasov D., Kononkov I.

Neoadjuvant systemic therapy of HER2-positive breast cancer

Frolova M.

卷 17, 编号 1 (2015)

Radiation-induced lung injury in breast cancer patients after breast conservation therapy

Trofimova O., Tkachev S., Ivanov S., Utkina V., Cheban O., Glebovskaya V.

卷 16, 编号 3 (2014)

Current algorhytm of screening and early diagnosis of hepatocellular carcinoma

Tikhonov I., Pavlov C., Mayevskaya M., Ivashkin V.

卷 16, 编号 3 (2014)

Personalized approach to HER2-positive advanced breast cancertherapy

Stenina M.

卷 15, 编号 4 (2013)

The role of angiogenesis blockers in the treatment of metastatic ovarian cancer

Oganian M., Kazantseva M., Davidenko I., Porhanova N.

卷 15, 编号 4 (2013)

The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC

Orlov S.

卷 15, 编号 2 (2013)

New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer

Artamonova E., Manzyuk L.

Malignant neoplasm of the bronchi and lung: Russian clinical guidelines

Laktionov K., Artamonova E., Borisova T., Breder V., Bychkov I., Vladimirova L., Volkov N., Ergnian S., Zhabina A., Kononets P., Kuz’minov A., Levchenko E., Malikhova O., Marinov D., Miller S., Moiseenko F., Mochal’nikova V., Novikov S., Pikin O., Reutova E., Rodionov E., Sakaeva D., Semenova A., Smolin A., Sotnikov V., Tuzikov S., Turkin I., Tiurin I., Chkhikvadze V., Kolbanov K., Chernichenko A., Fedenko A., Filonenko E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T., Butenko A., Gil’mutdinova I., Gridneva I., Eremushkin M., Zernova M., Kasparov B., Kovlen D., Kondrat’eva K., Konchugova T., Korotkova S., Krutov A., Obukhova O., Ponomarenko G., Semiglazova T., Stepanova A., Tkachenko G., Khulamkhanova M.

(Rus)

PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021

Board E.

(Rus)

Synchronous thyroid gland metastases from breast cancer. Case reports

Ognerubov N., Antipova T., Palkina E.

(Rus)

Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma

Ignatova A.

(Rus)

Breast cancer

Zhukova L., Andreeva I., Zavalishina L., Zakiriakhodzhaev A., Koroleva I., Nazarenko A., Paltuev R., Parokonnaia A., Petrovskii A., Portnoi S., Semiglazov V., Semiglazova T., Stenina M., Stepanova A., Trofimova O., Tyulyandin S., Frank G., Frolova M., Shatova I., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.

(Rus)

卷 22, 编号 4 (2020)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer

Ganshina I., Gordeeva O., Manukian M.

(Rus)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma

Bolotina L.

(Rus)

Opportunities for metastatic triple negative breast cancer therapy

Ganshina I., Gordeeva O., Manukyan M.

(Rus)

卷 21, 编号 2 (2019)

The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience

Kolyadina I., Bulavina I., Petkau V., Strakhova N., Gorbunova V., Kovalenko E., Manziuk L., Artamonova E., Zhukova L., Bolotina L., Gan'shina I., Semiglazova T., Manikhas A., Raevskaia N., Itkin I., Khokhlova S., Filonenko D., Gol'dberg V., Popova N., Ponomarenko D., Shikina V., Vladimirova L., Tikhanovskaia N., Karabina E., Mukhametshina G., Khasanova A., Safina S., Shaidorov M., Orlov A., Kostalanova I., Levchenko N., Osipov M., Karandeeva T., Evstigneeva I., Chernov I., Kolokolov D., Povyshev A., Shatokhina A., Cherniakova E., Shkodenko O., Kuz'mina E.

(Rus)

卷 20, 编号 2 (2018)

The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)

Stepanova A., Merzlyakova A., Khulamhanova M., Trofimova O.

(Rus)

卷 20, 编号 1 (2018)

Dermatomyositis and polymyositis in breast cancer patients: a case reports

Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.

(Rus)

卷 19, 编号 3 (2017)

Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving

Artamonova E.

(Rus)

The treatment of patients with advanced lung cancer associated with EGFR mutation

Bolotina L.

(Rus)

Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene

Ryazhenov V., Gorokhova S.

(Rus)

卷 18, 编号 2 (2016)

Long-term treatment of neuroendocrine tumor of the pancreas

Khvastunov R., Egorov S., Kargin A., Kim A.

(Rus)

The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia

Bolotina L., Manziuk L., Gorbunova V., Kovalenko E., Mukhametshina G., Khasanova A., Vladimirova L., Mitashok I., Prokofyeva E., Evstigneeva I., Andreyashkina I., Abramova N., Popova I., Karabina E., Teterich A., Gaysina E., Chubenko V., Limareva S., Tikhanovskaya N., Storozhakova A., Samaneva N., Svetitskaya Y., Snezhko T., Kalabanova E.

(Rus)

卷 18, 编号 1 (2016)

Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy

Kolyadina I., Poddubnaya I., Pavlikova O., Komov D.

(Rus)

卷 17, 编号 3 (2015)

Adenosquamous carcinoma of the colon: case report

Nefedova N., Kharlova O., Malkov P., Kharlov N., Danilova N.

Modern possibilities of targeted therapy in metastatic colorectal cancer

Gorbunova V.

卷 16, 编号 4 (2014)

Surgical results in patients 75 years and older with gastric cancer

Rokhoev G., Stilidi I., Nered S.

卷 16, 编号 4 (2014)

The effect of combinated treatment of a metastatic HER2-positive stomach cancer

Khvastunov R., Nenarokomov A., Tolstopiatov S., Babina K.

卷 16, 编号 2 (2014)

High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)

Seryakov A., Ovchinnikova L., Zabelin M., Yakubov T., Sidorov D., Ovchinnikov M.

卷 16, 编号 1 (2014)

The role of topotecan in prolongation of platinum-free interval in patients with recurrent ovarian cancer

Moskovskaya E., Novikova E., Korneeva I.

卷 15, 编号 4 (2013)

The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer

Cherkasova M., Khokhlova S., Limareva S., Bazaeva I., Orel N., Gorbunova V., Poddubnaya I.

卷 15, 编号 1 (2013)

Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results

Garbuzov M.

Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic

Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.

(Rus)

Antiangiogenic therapy for breast cancer with triple negative phenotype

Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.

(Rus)

Can any breast skin thickening be staged as T4?

Amosova V., Petrovskii A., Karpova M., Ponedel’nikova N., Frolova M.

(Rus)

卷 22, 编号 4 (2020)

The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

Mazurina N., Artamonova E., Beloyartseva M., Volkova E., Ganshina I., Troshina E., Tjulandin S., Chubenko V.

(Rus)

Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy

Kononenko I., Snegovoy A., Grebennikova O., Sel’chuk V., Palchinskaia O.

(Rus)

卷 22, 编号 2 (2020)

Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case

Gorbunova T., Radtsig E., Merkulov O., Bogomil’skii M., Poliakov V.

(Rus)

卷 21, 编号 2 (2019)

The use of regorafenib in colorectal cancer

Sekacheva M., Bagmet N., Guryanova A., Rashi D.

(Rus)

卷 20, 编号 4 (2018)

The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer

Saevets V., Vazhenin A., Chernova L., Shimotkina I., Kurchenkova O., Mukhin A., Taratonov A.

(Rus)

卷 20, 编号 1 (2018)

Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series

Orlova R., Zhukova L., Ganshina I., Yukalchuk D., Ponomarenko D., Beliak N., Gordeeva O., Erdniev S., Minasyan A., Dashkova A., Sopiya E., Sholokhova E., Gurochkin A.

(Rus)

Clinico-morphological predictors and treatment outcomes in cervical stump cancer

Usmanova L., Kuznetsov V., Mustafina E., Barinov V., Bokin I., Knyazev R., Akhmedova M.

(Rus)